Emily M. Leproust, Chief Executive Officer at Twist Bioscience Corp (TWST), sold 9,671 shares at $65.01 ($631K) on 2026-04-21, disclosed to the SEC on 2026-04-23.
Scheduled sale ($631k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.01 | 1,610 | $105K | 16.6% |
| 2 | $65.28 | 7,910 | $516K | 81.8% |
| 3 | $66.00 | 151 | $10K | 1.6% |
| Total | $65.24 avg | 9,671 | $631K | 100% |
| Filing → |
| TWST | SELL | 2026-09-25 | $923K | — | Filing → |
| TWST | SELL | 2026-09-23 | $279K | — | Filing → |
| TWST | SELL | 2026-09-21 | $56.3M | — | Filing → |